Skip to content
Open access

Multi-omics analysis of histidine metabolism reveals FRZB-CRYM-associated cellular crosstalk in heart failure

Aug 2026 · Frontiers in Cardiovascular Medicine · Vol 13 · 0 citations · 40 references
Medicine

TL;DR

This study systematically characterizes the potential role of histidine metabolism dysfunction in HF and supports a model of a putative “stroma-myocardium” positive feedback loop associated with FRZB (in stromal cells) and CRYM (in cardiomyocytes).

Abstract

Background The role of histidine metabolism in heart failure (HF), particularly its heterogeneous regulation across cardiac cell types, remains unclear. This study aims to define its mechanistic basis and identify key regulatory genes. Methods We integrated multiple transcriptomic datasets, including four conventional and three single-cell RNA-seq (scRNA-seq) cohorts from the GEO database. A multi-step computational biology pipeline was employed, comprising gene set enrichment analysis (e.g., AUCell, ssGSEA), multidimensional machine learning (14 algorithms, e.g., LASSO, random forest), differential expression analysis, and cell-cell communication inference (CellChat, MultiNicheNet) to identify and validate core targets. Results We identified significant activation of the histidine metabolism pathway in the heart failure (HF) microenvironment, particularly within fibroblast and myeloid cells. A high-histidine-metabolism macrophage subpopulation (GPNMB+) exhibited enriched energy metabolism and upregulated MHC-II signaling, while a corresponding fibroblast subpopulation (Fib_THY1) showed enhanced immune communication. From 23 candidates, a rigorous machine learning strategy pinpointed FRZB and CRYM as core targets. These genes were markedly upregulated in HF, demonstrated reliable diagnostic value (AUC: 0.87–0.98), and correlated strongly with histidine metabolism. Crucially, scRNA-seq revealed distinct cellular localization: CRYM in cardiomyocytes and FRZB in mesenchymal stromal cells. Cell communication analysis suggested a putative pathological positive feedback loop wherein FRZB+ stromal cells are predicted to influence metabolic reprogramming in cardiomyocytes. This study proposes a novel model of a “stroma-myocardium” feedback loop. Conclusion This study systematically characterizes the potential role of histidine metabolism dysfunction in HF and supports a model of a putative “stroma-myocardium” positive feedback loop associated with FRZB (in stromal cells) and CRYM (in cardiomyocytes). These computational inferences position FRZB and CRYM as candidate biomarkers, while their regulatory axis provides a novel theoretical framework for potential therapeutic targets in HF.

Read PDF

Similar papers

Open access Sep 2026

Integrated analysis of bulk transcriptomics and single-cell transcriptomics revealed the association characteristics between heart failure and β-hydroxybutyrylation-related genes

Functional enrichment analyses demonstrated that HMOX2 and KPNA2 were identified as Kbhb-related biomarkers in HF, while T cells served as a key cell type in the disease, and novel therapeutic targets for HF patients were provided.

Qing-Kuan Li, Xi-Yong Sheng, Gui-Hua Li et al. · 0 citations
Open access Sep 2026

Single-cell RNA-seq and machine learning identify HMGN2 as a lactylation-associated hub gene in heart failure

Heart failure (HF) is a diverse condition characterized by dysregulated lactate metabolism and histone lactylation, which may contribute to maladaptive cardiac remodeling. However, the cell type-specific mechanisms underlying these processes remain poorly understood. To address this gap, we integrated single-cell RNA s...

An-Zhen Xu, Yan-Bo Li, Qing Gong et al. · 0 citations
Sep 2026

Single-cell transcriptomics and multi-omics integration identify necroptosis-driven core targets and tubular-immune crosstalk in chronic kidney disease.

BACKGROUND Current pharmacotherapies for chronic kidney disease (CKD) are limited by adverse effects and a "one-target-one-drug" paradigm. Necroptosis is a key driver of renal deterioration, yet its regulatory network remains poorly defined. Modified Da-Huang-Fu-Zi Decoction (DHFZ) has shown clinical efficacy, although...

Si-Teng Zhang, Wei Zhu, Guo-Fang Huang et al. · 0 citations
Open access Aug 2026

Integrative Transcriptomic Analysis Identifies Glycolysis/Ferroptosis-Associated Candidate Genes in Gastric Cancer

Background: The crosstalk between glycolysis, ferroptosis and the gastric cancer (GC) immune microenvironment remains poorly defined. This study aims to uncover glycolysis/ferroptosis-related regulators of the GC immune microenvironment.Methods: Transcriptomic datasets from The Cancer Genome Atlas (TCGA)-Stomach adenoc...

Yong-Ting Lan, Xin Zhou, Yongfen Ma et al. · 0 citations
Open access Sep 2026

Network-guided multi-omics characterizes stress-associated transcriptional and metabolic alterations in PFOA-exposed HK-2 proximal tubular cells.

Perfluorooctanoic acid (PFOA) is a persistent per- and polyfluoroalkyl substance that undergoes active renal handling, yet the molecular response of proximal tubular cells remains poorly resolved. We integrated network toxicology with matched RNA sequencing and untargeted LC-MS metabolomics in PFOA-exposed HK-2 cells,...

Yi-Wei Shang, Qi-Kai Luo, You-Rou Zhou et al. · 0 citations
Open access Oct 2026

Multi-omics analysis of hypoxia-mitochondrial energy metabolism and programmed cell death profiling in Parkinson’s disease

Hypoxia and mitochondrial energy metabolism (MEM) impairment are pivotal features of Parkinson’s disease (PD), yet the regulators linking hypoxic stress to mitochondrial failure remain elusive. Here we integrated multiple transcriptomic datasets from the substantia nigra to characterize the hypoxia and MEM landscape....

An Chang, Yi Wu, Piao-Piao Lian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.